Evofem Strengthens Phexxi® Intellectual Property with New Composition of Matter Patent From USPTO
June 30, 2022
Cannabics Pharmaceuticals Files a PCT Patent Application for Proprietary Cancer Treatment Formulations
May 11, 2021
Related Post
-
-
Sugarmade Announces Fully Executed LOI Toward Minority Stake Acquisition of Turnkey Cannabis Cultivation Property
June 30, 2022
-
Todos Medical Announces Positive Biomarker Data from Phase 2 Trial of Tollovir in Hospitalized COVID-19 Patients
June 30, 2022
-
CBD Global Issues Fourth Bi-Weekly Report and Provides Update on Delayed Annual Filings
June 29, 2022